@article{ab00804fad524805bafed18f36f6411e,
title = "ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization",
abstract = "Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.",
keywords = "Appropriate use, Cardiac amyloidosis, Diagnosis, Expert consensus, Multimodality",
author = "Sharmila Dorbala and Yukio Ando and Sabahat Bokhari and Angela Dispenzieri and Falk, {Rodney H.} and Ferrari, {Victor A.} and Marianna Fontana and Olivier Gheysens and Gillmore, {Julian D.} and Glaudemans, {Andor W.J.M.} and Hanna, {Mazen A.} and Hazenberg, {Bouke P.C.} and Kristen, {Arnt V.} and Kwong, {Raymond Y.} and Maurer, {Mathew S.} and Giampaolo Merlini and Miller, {Edward J.} and Moon, {James C.} and Murthy, {Venkatesh L.} and Quarta, {C. Cristina} and Claudio Rapezzi and Ruberg, {Frederick L.} and Shah, {Sanjiv J.} and Slart, {Riemer H.J.A.} and Verberne, {Hein J.} and Bourque, {Jamieson M.}",
note = "Publisher Copyright: {\textcopyright} 2019, American Society of Nuclear Cardiology, Heart Failure Society of America, and American Heart Association.",
year = "2019",
doi = "10.1007/s12350-019-01761-5",
language = "English (US)",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
}